Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04505865 · ClinicalTrials.gov registry record · NA

The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease

A NA study of Stress and Inflammation, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT04505865 is a NA study of Stress and Inflammation that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 36 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04505865, a NA study of Stress and Inflammation, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the effect of 8 weeks of a stress reduction intervention on atherosclerotic plaque inflammation in adults with stable coronary artery disease, as quantified by positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in individuals with increased psychosocial stress.

Interventions

  • BEHAVIORAL Stress Reduction

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2021-11-01
Est. Completion 2026-12-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04505865

The ClinicalTrials.gov registry entry for NCT04505865 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 152 other Stress trials with a reported enrollment target (95% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Stress Reduction is the first listed.

NCT04505865 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04505865 about?

NCT04505865 is a clinical study titled "The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease". This study aims to evaluate the effect of 8 weeks of a stress reduction intervention on atherosclerotic plaque inflammation in adults with stable coronary artery disease, as quantified by positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in individuals with increased psychosocial ...

What is the current status of trial NCT04505865?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2021-11-01. Estimated completion is 2026-12-31.

What conditions does trial NCT04505865 study?

This clinical trial studies the following conditions: Stress, Inflammation, Atherosclerosis.

What interventions are being tested in trial NCT04505865?

The interventions under investigation include: Stress Reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT04505865?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04505865 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.